Bolt Biotherapeutics, Inc.
BOLT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001641281
In the last 90 days, Bolt Biotherapeutics, Inc. insiders filed 2 open-market purchases and 3 sales; 23 institutions reported holding it in 13F filings for Q2 2026, worth $2.31M in total; no superinvestor holds it.
13F holders, Q4 2023
Institutional positions in Bolt Biotherapeutics, Inc. as of Dec 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +6 vs. Q3 2023
- Shares held
- 24.1M
- −1.34K (0.0%) vs. Q3 2023
- Total value
- $27.0M
- +$1.93M (+7.7%) vs. Q3 2023
- New holders
- 7
- 9 more added
- Sold out
- 1
- 12 more reduced
1 institution that held it in Q3 2023 haven't filed for Q4 2023 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting BOLT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 23 | $2.31M |
| Q1 2026 | 24 | $2.49M |
| Q4 2025 | 21 | $3.30M |
| Q3 2025 | 24 | $4.28M |
| Q2 2025 | 25 | $5.10M |
| Q1 2025 | 30 | $7.33M |
| Q4 2024 | 38 | $9.99M |
| Q3 2024 | 32 | $12.2M |
| Q2 2024 | 37 | $17.0M |
| Q1 2024 | 39 | $33.6M |
| Q4 2023 | 40 | $27.0M |
| Q3 2023 | 35 | $25.5M |
| Q2 2023 | 40 | $32.1M |
| Q1 2023 | 41 | $32.4M |
| Q4 2022 | 44 | $26.8M |
| Q3 2022 | 56 | $39.7M |
| Q2 2022 | 62 | $54.8M |
| Q1 2022 | 66 | $79.3M |
| Q4 2021 | 62 | $164.6M |
| Q3 2021 | 72 | $449.1M |
| Q2 2021 | 61 | $513.8M |
| Q1 2021 | 70 | $1.04B |
Institutions, Q4 2023
Shares, value and share of portfolio for each institution holding Bolt Biotherapeutics, Inc.; share changes are against Q3 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 465 | $0 | 0.00% | +371+394.7% | Added |
| Qube Research & Technologies Ltd | 2 | $2 | 0.00% | 00.0% | Unchanged |
| Salem Investment Counselors Inc | 40 | $45 | 0.00% | 00.0% | Unchanged |
| Barclays PLC | 139 | $156 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 207 | $232 | 0.00% | +10+5.1% | Added |
| Bank of America Corp | 628 | $703 | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 840 | $941 | 0.00% | −75,447−98.9% | Reduced |
| Citigroup Inc | 2,307 | $2.58K | 0.00% | +2,307 | New |
| Advisor Group Holdings, Inc. | 3,978 | $4.46K | 0.00% | +3,978 | New |
| UBS Group AG | 7,651 | $8.57K | 0.00% | +7,565+8,796.5% | Added |
| Tower Research Capital LLC (TRC) | 8,236 | $9.22K | 0.00% | +8,236 | New |
| Prudential Financial Inc | 12,200 | $13.7K | 0.00% | +12,200 | New |
| XTX Topco Ltd | 19,152 | $21.4K | 0.00% | +19,152 | New |
| Northern Trust Corp | 41,005 | $45.9K | 0.00% | +9,823+31.5% | Added |
| Millennium Management LLC | 47,007 | $52.6K | 0.00% | +2,024+4.5% | Added |
| State Street Corp | 47,437 | $53.1K | 0.00% | −1,300−2.7% | Reduced |
| Jane Street Group, LLC | 56,264 | $63.0K | 0.00% | +56,264 | New |
| Two Sigma Securities, LLC | 64,232 | $71.9K | 0.00% | +64,232 | New |
| FMR LLC | 79,193 | $88.7K | 0.00% | −30.0% | Reduced |
| Morgan Stanley | 79,394 | $88.9K | 0.00% | −80,374−50.3% | Reduced |
| Squarepoint Ops LLC | 79,772 | $89.3K | 0.00% | −265−0.3% | Reduced |
| Marquette Asset Management, LLC | 96,673 | $108.3K | 0.02% | −1,162−1.2% | Reduced |
| Bridgeway Capital Management, LLC | 111,200 | $124.5K | 0.00% | 00.0% | Unchanged |
| Privium Fund Management (UK) Ltd | 116,516 | $130.5K | 0.09% | 00.0% | Unchanged |
| BlackRock Inc. | 257,271 | $288.1K | 0.00% | −752−0.3% | Reduced |
| Geode Capital Management, LLC | 350,164 | $392.3K | 0.00% | −10,575−2.9% | Reduced |
| Renaissance Technologies LLC | 445,273 | $499.0K | 0.00% | +131,084+41.7% | Added |
| Acuitas Investments, LLC | 459,455 | $514.6K | 0.27% | −924−0.2% | Reduced |
| Adage Capital Partners GP, L.L.C. | 500,000 | $560.0K | 0.00% | 00.0% | Unchanged |
| Board of Trustees of The Leland Stanford Junior University | 719,546 | $805.9K | 0.05% | −37,551−5.0% | Reduced |
| Vanguard Group Inc | 931,129 | $1.04M | 0.00% | +6,864+0.7% | Added |
| Samsara BioCapital, LLC | 1,049,153 | $1.18M | 0.18% | 00.0% | Unchanged |
| Nan Fung Group Holdings Ltd | 1,166,952 | $1.31M | 0.81% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 1,541,000 | $1.73M | 0.03% | 00.0% | Unchanged |
| Newtyn Management, LLC | 1,553,535 | $1.74M | 0.34% | +533,535+52.3% | Added |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,891,467 | $2.12M | 0.54% | 00.0% | Unchanged |
| Citadel Advisors LLC | 2,458,958 | $2.75M | 0.00% | −394,676−13.8% | Reduced |
| Sofinnova Investments, Inc. | 2,754,437 | $3.08M | 0.17% | 00.0% | Unchanged |
| Vivo Capital, LLC | 3,521,291 | $3.94M | 0.32% | −350,000−9.0% | Reduced |
| Tang Capital Management LLC | 3,652,244 | $4.09M | 0.38% | +95,204+2.7% | Added |
| Federated Hermes, Inc. | 0 | $0 | 0.00% | −1,161−100.0% | Sold out |
| Hawkeye Capital Management, LLC | – | – | – | – | Not filed |